quinapril has been researched along with Proteinuria in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhaheetharan, S; Ferdinand, KC; Haque, T; Khan, BV; Merchant, N; Rahman, ST; Wahi, J | 1 |
| Blanco, S; Casas, I; López, D; Penin, R; Romero, R | 1 |
| Alonso, C; Catalán, MP; Egido, J; Gallego-Delgado, J; Gómez-Garre, D; Largo, R; Ortiz, A; Plaza, JJ; Soto, K; Tejera, N | 1 |
| Chesney, R | 1 |
| Akashiba, A; Honda, T; Ishimitsu, T; Kameda, T; Matsuoka, H; Minami, J; Ohta, S; Ono, H; Takahashi, M; Takahashi, T; Yoshii, M | 1 |
| Chen, H; Clyne, S; Han, E; Harris, R; Lehrich, R; Lewis, J; Middleton, J; Rodby, R; Schulman, G; Shyr, Y; Sika, M; Sinsakul, M | 1 |
| Bruneval, P; Domergue, V; Fornes, P; Giudicelli, JF; Richer, C; Vacher, E | 1 |
| Bustos, C; Condom, E; Egido, J; González, E; González, S; Largo, R; Ortiz, A; Ruiz-Ortega, M; Serón, D | 1 |
| Barenbrock, M; Hausberg, M; Heidenreich, S; Hohage, H; Müller, S; Rahn, KH | 1 |
| Ferder, LF; Inserra, F; Porter, JR; Reisin, E; Richards, RJ; Stella, I; Svec, F | 1 |
| Bernal, R; Blanco, J; Egido, J; Gomez-Garre, D; Gomez-Guerrero, C; Lopez-Franco, O; Ortega, L; Sugaya, T; Suzuki, Y; Tejera, N | 1 |
| Fujita, T; Goto, A; Onozato, ML; Tojo, A; Wilcox, CS | 1 |
3 trial(s) available for quinapril and Proteinuria
| Article | Year |
|---|---|
The impact of lipoic acid on endothelial function and proteinuria in quinapril-treated diabetic patients with stage I hypertension: results from the QUALITY study.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Proteinuria; Quinapril; Tetrahydroisoquinolines; Thioctic Acid | 2012 |
A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Celecoxib; Creatinine; Cross-Over Studies; Cyclooxygenase Inhibitors; Diabetic Nephropathies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Middle Aged; Models, Statistical; Pilot Projects; Proteinuria; Pyrazoles; Quinapril; Sulfonamides; Tetrahydroisoquinolines | 2007 |
ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Creatinine; Cyclosporine; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Immunosuppressive Agents; Isoquinolines; Kidney Transplantation; Male; Middle Aged; Proteinuria; Quinapril; Tetrahydroisoquinolines | 1999 |
9 other study(ies) available for quinapril and Proteinuria
| Article | Year |
|---|---|
Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Desmin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; Disease Models, Animal; Drug Therapy, Combination; Linear Models; Male; Obesity; Podocytes; Proteinuria; Quinapril; Rats; Rats, Zucker; Tetrahydroisoquinolines | 2002 |
Tight blood pressure control decreases apoptosis during renal damage.
Topics: Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; Cell Division; Drug Therapy, Combination; Hydralazine; Hydrochlorothiazide; Hypertension, Renal; Immunohistochemistry; Losartan; Male; Proteinuria; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reserpine; Tetrahydroisoquinolines | 2004 |
The changing face of childhood nephrotic syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Child; Female; Glomerulosclerosis, Focal Segmental; Humans; Methylprednisolone; Nephrotic Syndrome; Proteinuria; Quinapril; Tetrahydroisoquinolines | 2004 |
Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Disease Models, Animal; Heart Rate; Heart Ventricles; Hypertension; Kidney; Kidney Diseases; Male; Nitrendipine; Organ Size; Proteinuria; Quinapril; Rats; Rats, Inbred SHR; Tetrahydroisoquinolines; Time Factors | 2006 |
Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Height; Body Weight; Brain; Cerebrovascular Disorders; Diuresis; Heart Rate; Hypertension; Incidence; Isoquinolines; Kidney; Male; Myocardium; Proteinuria; Quinapril; Rats; Rats, Inbred SHR; Risk Factors; Tetrahydroisoquinolines; Time Factors | 1993 |
ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoimmune Diseases; Cell Division; Extracellular Matrix; Female; Fluorescent Antibody Technique, Direct; Gene Expression; Isoquinolines; Nephritis, Interstitial; Peptidyl-Dipeptidase A; Proteinuria; Quinapril; Rats; Rats, Wistar; RNA, Messenger; Tetrahydroisoquinolines; Transforming Growth Factor beta | 1995 |
Effects of dehydroepiandrosterone and quinapril on nephropathy in obese Zucker rats.
Topics: Actins; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatinine; Dehydroepiandrosterone; Diuresis; Isoquinolines; Kidney; Kidney Diseases; Muscle, Smooth; Natriuresis; Obesity; Organ Size; Proteinuria; Quinapril; Rats; Rats, Zucker; Tetrahydroisoquinolines; Thinness; Tissue Distribution | 2001 |
Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bosentan; Endothelins; Extracellular Matrix; Isoquinolines; Kidney; Kidney Diseases; Kidney Tubules; Kinetics; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Proteinuria; Quinapril; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reference Values; RNA, Messenger; Serum Albumin, Bovine; Sulfonamides; Tetrahydroisoquinolines; Transcription Factor AP-1; Transforming Growth Factor beta | 2001 |
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; Female; Hydrogen Peroxide; Isoquinolines; Kidney; Lipid Peroxidation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphoproteins; Proteinuria; Quinapril; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Superoxides; Tetrahydroisoquinolines; Tetrazoles; Tyrosine | 2002 |